Wenjian Tang, Yuan Kang, Bo Lan, Zhiqiang Zhang, Jiawei Feng, Feng Li et al. Nomogram to predict the EGFR mutation status in stage III-IV solid lung adenocarcinoma patients. // BMC Medical Imaging. – 2025. – DOI: 10.1186/s12880-025-01922-8. – URL: https://doi.org/10.1186/s12880-025-01922-8
Wenjian Tang, Yuan Kang, Bo Lan, Zhiqiang Zhang, Jiawei Feng, Feng Li, Xinyi Zeng, Junyuan Zhong, Shuhua Luo, & Jianping Zhong (2025). Nomogram to predict the EGFR mutation status in stage III-IV solid lung adenocarcinoma patients. BMC Medical Imaging. https://doi.org/10.1186/s12880-025-01922-8
Wenjian Tang, et al. “Nomogram to predict the EGFR mutation status in stage III-IV solid lung adenocarcinoma patients.” BMC Medical Imaging, 2025. doi:10.1186/s12880-025-01922-8.
@article{Tang2025,
title = {Nomogram to predict the EGFR mutation status in stage III-IV solid lung adenocarcinoma patients},
author = {Tang, Wenjian and Kang, Yuan and Lan, Bo and Zhang, Zhiqiang and Feng, Jiawei and Li, Feng and Zeng, Xinyi and Zhong, Junyuan and Luo, Shuhua and Zhong, Jianping},
journal = {BMC Medical Imaging},
year = {2025},
doi = {10.1186/s12880-025-01922-8},
url = {https://doi.org/10.1186/s12880-025-01922-8}
}